Skip to main content
. Author manuscript; available in PMC: 2020 Oct 19.
Published in final edited form as: Ann Rheum Dis. 2019 Apr 24;78(7):988–995. doi: 10.1136/annrheumdis-2018-215004

Figure 1. Swarm plot of anti-Ro52 autoantibody ELISA results for juvenile healthy controls and JIIM patients divided into JDM, JPM, and JCTM.

Figure 1.

The dashed line of 20 units indicates the cut-off value for anti-Ro52 autoantibody positivity. Out of 371 JIIM patients, 53 (14%) were positive for anti-Ro52 autoantibodies by ELISA. Of these patients, 42 had JDM, 3 had JPM, and 8 had JCTM. Out of 90 juvenile healthy controls, one patient (1.1%) was positive for anti-Ro52 autoantibodies by ELISA.